Kaken Pharmaceutical Co., Ltd. (4521)
Market Closed
6 Oct, 06:00 AM
JPX JPX Primary 
OTC PINK ¥
3,770. 00
+15
+0.3995%
¥
146.55B Market Cap
- P/E Ratio
190% Div Yield
59,400 Volume
- Eps
¥ 3,755
Previous Close Want to track 4521 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kaken Pharmaceutical Co., Ltd. (4521) Statistics
Valuation metrics
Market Cap 146.55B
Enterprise value 86.42B
Trailing P/E (ttm) 13.61
Forward P/E 43.1
PEG ratio -0.03
Price/Sales (ttm) 1.59
Price/Book (mrq) 0.92
Enterprise Value/Revenue 0.98
Enterprise Value/EBITDA 5.23
Overview
Shares outstanding 37.87M
Float 32.45M
Shares short -
% Held by insiders 0.17%
% Held by institutions 0.21%
Average volume (10 days) 107.24K
Average volume (90 days) 116.21K
Price summary
52-Week low 3,540
52-Week high 4,445
Beta 0.13
50-Day moving average 3,917
200-Day moving average 3,965
Dividends and splits
Forward annual dividend rate 190
Forward annual dividend yield 0.0461%
Trailing annual dividend rate 190
Trailing annual dividend yield 0.0513%
5-Year annual dividend yield 3.92%
Payout ratio 11.85
Dividend Date 29 Sep 2026
Ex-Dividend Date 29 Sep 2026
Last split factor 1:2
Last split Date 28 Sep 2015
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.12%
Operating margin 0.11%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.07%
Income Statement
Revenue (ttm) 76.87B
Revenue per share (ttm) 2,328.02
Quarterly revenue growth (yoy) 0.07%
Gross profit (ttm) 39.99B
EBITDA 23.89B
Net income to common (ttm) 2.14B
Diluted EPS (ttm) 272.31
Quarterly earnings growth (yoy) -0.92%
Balance Sheet
Total cash (mrq) 50.7B
Total cash per share (mrq) 1,535.4
Total debt (mrq) 3.85B
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 4.18%
Book value per share (mrq) 4,037.29
Cash Flow
Cash flow statement -11.08B
Levered free cash flow (LFCF) -14.29B
2026 © Marketlog. All Rights Reserved.
